NovaBay Pharmaceuticals Inc (B9P.SG)
| Previous close | 0.0775 |
| Open | 0.0780 |
| Bid | 0.0725 x N/A |
| Ask | 0.0895 x N/A |
| Day's range | 0.0780 - 0.0785 |
| 52-week range | 0.0625 - 0.8850 |
| Volume | |
| Avg. volume | 666 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call Transcript
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call Transcript March 26, 2024 NovaBay Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.95 EPS, expectations were $-0.3. NBY isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and welcome to […]
- Thomson Reuters StreetEvents
Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call
Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call
- Insider Monkey
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q3 2023 Earnings Call Transcript
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q3 2023 Earnings Call Transcript November 9, 2023 Operator: Welcome to the NovaBay Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to Ms. Jody Cain. Please go ahead, ma’am. Jody Cain: This […]
